This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
Clinical trial NCT03230097 · TERMINATED
Trial details
- NCT number
- NCT03230097
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-29
- Primary completion
- 2021-03-17
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.